about
DSM-5: disruptive mood dysregulation disorderCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersExcessive mood elevation and behavioral activation with antidepressant treatment of juvenile depressive and anxiety disorders: a systematic reviewShould the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder.Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors.Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths.Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review.Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patientsInitiation of stimulant and antidepressant medication and clinical presentation in juvenile bipolar I disorderNeuropsychiatric disorders associated with streptococcal infection: a case-control study among privately insured children.Challenges in the diagnosis and treatment of pediatric bipolar depression.Assessment and management of treatment-refractory obsessive-compulsive disorder in children.The use of selective serotonin reuptake inhibitors in children and adolescents with major depression.Review of the efficacy and safety of antidepressants in youth depression.The risks and benefits of antidepressant treatment for youth depression.Interventions for youth at high risk for bipolar disorder and schizophrenia.Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study.Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Antidepressants and suicidal behavior in bipolar disorder.Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice.New-generation antidepressants, suicide and depressed adolescents: how should clinicians respond to changing evidence?Phenomenology, longitudinal course, and outcome of children and adolescents with bipolar spectrum disorders.Adolescent major depression: challenges to treatment.Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces.Pharmacotherapy of major depressive disorder in adolescents.Pharmacotherapy and psychotherapy of pediatric depression.Antidepressants and psychostimulants in pediatric populations: is there an association with mania?Escitalopram for the treatment of major depressive disorder in youth.Treatment-resistant depression in adolescents: review and updates on clinical management.Overview of antidepressant treatment of bipolar depression.The use of antidepressants in bipolar disorder patients with depression.Ethical considerations in preventive interventions for bipolar disorder.Role of Omega-3 Fatty Acids in the Etiology, Treatment, and Prevention of Depression: Current Status and Future Directions.Manic switches induced by antidepressants: an umbrella review comparing randomized controlled trials and observational studies.Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.Nationwide and population-based prescription patterns in bipolar disorder.Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents.Iatrogenic comorbidity in childhood and adolescence: new insights from the use of antidepressant drugs.Database Analysis of Depression and Anxiety in a Community Sample-Response to a Micronutrient Intervention.
P2860
Q26853229-1FC7D139-F6CF-43B3-887F-3293BE20F7A2Q27009995-4F8FA4CE-3081-4A83-A9C1-8117158B3729Q27021267-0B695CE1-59D4-414B-A23F-66991ED23CB0Q28279067-1F9BE1DB-9A2E-43CE-9AFE-8B46F396D517Q33714517-7CD344FB-CB91-4FD6-B51C-F0C16847D845Q34019994-58B16939-DA9F-4902-9EDC-887F1277BA48Q34152823-E525356E-081F-46A9-97A3-196A9F577B44Q34318546-EBF42C51-1B06-44BF-8707-E9AE8C9806CEQ34368534-AD68CDFE-4D4B-4C30-A599-472D8F541589Q34422709-258BD9AD-45BD-4AFE-A868-91E56CB606F5Q34812790-EC7B6644-44BB-42F5-B0D4-015207E9B87DQ35237072-011A5DC5-7936-496E-A972-5FCF89EE6E91Q35697831-C4F56EA2-BBDF-4340-840D-1F5E74BA44FCQ36168586-F882B134-B3D9-435E-8199-AE6DD6ECDAC1Q36171352-6DFD7E0C-18BE-4D65-A59E-E562BCCC8171Q36276293-E3BBEE73-C0B5-4037-A617-005119468F91Q36303876-8050092C-4106-4357-AFB9-592C24A3BF5FQ36374021-AEF2EA04-0BAD-47AD-A7C0-D694A6184421Q36502629-3C5F76AD-56A5-4895-A502-AFC4AD9F07D1Q36624146-A78E24CD-4838-4591-93B6-CD40F12ED526Q36773267-0F466A52-B4A9-4B19-8B70-E5AD63B1DB15Q37157631-E68C54E4-1E01-41C0-A2E5-4068C0CAA9E3Q37268232-1B12623C-7DC6-4F01-957B-5F4D5A4F5391Q37406197-5E963873-CC7C-459A-9517-C51C56CE061FQ37668134-13C63D76-B3A8-4B8A-AD36-D4384665C864Q37681565-ADDE849B-7275-4249-A72F-D5C5EFF269FEQ37779801-126AF737-7FBC-44FB-ABB9-395FD1E5FFF3Q37892521-4AE55DBE-10FD-42B0-874C-96161B27B7E7Q37927104-A174C7D2-298A-4D51-AE63-1D12ED1D5F9CQ37928596-7FE7E8D5-F51A-4DEA-A699-9FDDAA1262EFQ38083305-B3EF045B-F6FB-4D59-B038-F6A236DEEED4Q38610748-183108AB-C6BD-49AD-9804-35E290BC44F5Q38793543-8F11CA69-0084-4C85-9F74-E7CBC33ED4C7Q38808320-F5256E10-025A-4EEF-853C-0B04184F9A80Q39017799-11DB512A-B07E-4456-A220-8ADF91D6F688Q39285492-3346D4F9-F8A7-45E2-A284-483FB5471F44Q39987572-93DD2289-73E5-426C-987E-8B3E44F65F24Q43660474-87B94599-0ADA-4540-8AC5-1FFAFE27AA17Q44798643-AD96F6A0-8453-4795-BBC9-D3F6DD53706CQ47550294-A2650D02-835B-4767-8358-E505AFB37EF6
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Age effects on antidepressant-induced manic conversion.
@en
Age effects on antidepressant-induced manic conversion.
@nl
type
label
Age effects on antidepressant-induced manic conversion.
@en
Age effects on antidepressant-induced manic conversion.
@nl
prefLabel
Age effects on antidepressant-induced manic conversion.
@en
Age effects on antidepressant-induced manic conversion.
@nl
P2093
P1433
P1476
Age effects on antidepressant-induced manic conversion.
@en
P2093
Andrés Martin
Chengeto Mukonoweshuro
Christopher Young
Douglas Leslie
James F Leckman
P304
P356
10.1001/ARCHPEDI.158.8.773
P407
P577
2004-08-01T00:00:00Z